Stock Earnings

Question 1

What are Genomma Lab Internacional SAB de CV's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Genomma Lab Internacional SAB de CV has a total asset of $23,017, Net profit of $1,493

Question 2

What are the key financial ratios for GNMLF?

Accepted Answer

Genomma Lab Internacional SAB de CV's Current ratio is 1.89, has a Net margin is 8.02, sales per share of $19.01.

Question 3

How is Genomma Lab Internacional SAB de CV's revenue broken down by segment or geography?

Accepted Answer

Currently Genomma Lab Internacional SAB de CV data is not available.

Question 4

Is Genomma Lab Internacional SAB de CV profitable?

Accepted Answer

yes, according to the latest financial statements, Genomma Lab Internacional SAB de CV has a net profit of $1,493

Question 5

Does Genomma Lab Internacional SAB de CV have any liabilities?

Accepted Answer

yes, Genomma Lab Internacional SAB de CV has liability of 12,132

Question 6

How many outstanding shares for Genomma Lab Internacional SAB de CV?

Accepted Answer

Genomma Lab Internacional SAB de CV has a total outstanding shares of 977.75

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	18,189	18,606	16,467	16,819	15,487	13,870
Revenue Growth (YoY)	4%	13%	-2%	9%	12%	9%
Cost of Revenue	6,675	6,675	6,383	6,656	5,923	5,282
Gross Profit	11,514	11,931	10,083	10,163	9,563	8,588
Selling, General & Admin	7,654	8,055	6,888	6,922	6,570	5,665
Research & Development	--	--	--	--	--	--
Operating Expenses	7,602	8,017	6,876	6,920	6,506	5,819
Other Non Operating Income (Expenses)	-438	-363	-264	-394	-329	-178
Pretax Income	2,464	2,891	1,720	2,234	2,221	2,170
Income Tax Expense	749	799	635	867	914	766
Net Income	1,117	1,493	1,026	1,389	1,307	1,403
Net Income Growth	-30%	46%	-26%	6%	-7%	87%
Shares Outstanding (Diluted)	986.51	978.43	957.34	993.22	1,007.62	1,011.8
Shares Change (YoY)	5%	2%	-4%	-1%	0%	0%
EPS (Diluted)	1.13	1.52	1.07	1.39	1.29	1.38
EPS Growth	-33%	42%	-23%	7%	-6%	87%
Free Cash Flow	1,529	2,087	1,919	1,632	631	1,009
Free Cash Flow Per Share	1.54	2.13	2	1.64	0.62	0.99
Gross Margin	63.3%	64.12%	61.23%	60.42%	61.74%	61.91%
Operating Margin	21.5%	21.03%	19.47%	19.28%	19.73%	19.96%
Profit Margin	6.14%	8.02%	6.23%	8.25%	8.43%	10.11%
Free Cash Flow Margin	8.4%	11.21%	11.65%	9.7%	4.07%	7.27%
EBITDA	4,317	4,272	3,434	3,470	3,226	2,927
EBITDA Margin	23.73%	22.96%	20.85%	20.63%	20.83%	21.1%
D&A For EBITDA	405	359	227	227	170	158
EBIT	3,912	3,913	3,207	3,243	3,056	2,769
EBIT Margin	21.5%	21.03%	19.47%	19.28%	19.73%	19.96%
Effective Tax Rate	30.39%	27.63%	36.91%	38.8%	41.15%	35.29%

Genomma Lab Internacional SAB de CV (GNMLF) Price